Top Healthcare companies in United States by Debt to Equity Ratio

This ranking features the top 444 Healthcare companies in United States ranked by Debt to Equity Ratio, averaging a Debt to Equity Ratio of 0.50, for February 04, 2025.

United States

Healthcare

#	Name	Debt to Equity Ratio	Reported Date	Stock Price	Change	Country
1	Organon & Co. 1 OGN	56.71	Sept. 30, 2024	USD 14.91	-4.18%	United States
2	Guardant Health, Inc. 2 GH	32.57	Sept. 30, 2024	USD 47.57	1.26%	United States
3	Sonida Senior Living, Inc. 3 SNDA	27.27	Sept. 30, 2024	USD 23.74	2.81%	United States
4	ModivCare Inc. 4 MODV	16.74	Sept. 30, 2024	USD 3.84	-4.00%	United States
5	DaVita Inc. 5 DVA	15.60	Sept. 30, 2024	USD 177.06	0.49%	United States
6	Brookdale Senior Living Inc. 6 BKD	13.70	Sept. 30, 2024	USD 4.59	-0.86%	United States
7	Amgen Inc. 7 AMGN	10.19	Sept. 30, 2024	USD 288.87	1.21%	United States
8	AbbVie Inc. 8 ABBV	8.82	Sept. 30, 2024	USD 190.14	3.39%	United States
9	Travere Therapeutics, Inc. 9 TVTX	6.22	Sept. 30, 2024	USD 20.22	-1.17%	United States
10	Halozyme Therapeutics, Inc. 10 HALO	6.05	Sept. 30, 2024	USD 56.28	-0.64%	United States
11	Cencora 11 COR	5.16	Sept. 30, 2024	USD 254.43	0.09%	United States
12	Rani Therapeutics Holdings, Inc. 12 RANI	5.13	Sept. 30, 2024	USD 1.36	-2.16%	United States
13	iRhythm Technologies, Inc. 13 IRTC	4.96	Sept. 30, 2024	USD 108.88	0.03%	United States
14	Albertsons Companies, Inc. 14 ACI	4.71	Nov. 30, 2024	USD 19.58	-2.34%	United States
15	European Wax Center, Inc. 15 EWCZ	4.70	Oct. 5, 2024	USD 6.70	-0.74%	United States
16	Accuray Incorporated 16 ARAY	4.63	Sept. 30, 2024	USD 2.19	-1.79%	United States
17	Tenet Healthcare Corporation 17 THC	4.43	Sept. 30, 2024	USD 144.64	2.66%	United States
18	Ionis Pharmaceuticals, Inc. 18 IONS	4.25	Sept. 30, 2024	USD 32.13	0.72%	United States
19	Fortress Biotech, Inc. 19 FBIO	3.99	Sept. 30, 2024	USD 1.83	0.55%	United States
20	Biodesix, Inc. 20 BDSX	3.88	Sept. 30, 2024	USD 1.01	-1.94%	United States
21	Kala Pharmaceuticals, Inc. 21 KALA	3.73	June 30, 2024	USD 9.22	0.22%	United States
22	Select Medical Holdings Corporation 22 SEM	3.28	Sept. 30, 2024	USD 20.18	2.59%	United States
23	AnaptysBio, Inc. 23 ANAB	3.22	Sept. 30, 2024	USD 16.66	-7.08%	United States
24	Collegium Pharmaceutical, Inc. 24 COLL	3.15	Sept. 30, 2024	USD 31.20	-2.86%	United States
25	Humacyte, Inc. 25 HUMA	3.13	June 30, 2024	USD 4.30	-6.11%	United States
26	TransMedics Group, Inc. 26 TMDX	2.97	Sept. 30, 2024	USD 68.76	1.79%	United States
27	Amicus Therapeutics, Inc. 27 FOLD	2.95	Sept. 30, 2024	USD 9.64	0.63%	United States
28	Akoya Biosciences, Inc. 28 AKYA	2.78	Sept. 30, 2024	USD 2.74	-6.16%	United States
29	Walgreens Boots Alliance, Inc. 29 WBA	2.71	Nov. 30, 2024	USD 9.76	-5.06%	United States
30	Owens & Minor, Inc. 30 OMI	2.62	Sept. 30, 2024	USD 9.23	-35.18%	United States
31	Neuronetics, Inc. 31 STIM	2.61	Sept. 30, 2024	USD 3.20	3.23%	United States
32	Bristol-Myers Squibb Company 32 BMY	2.55	Sept. 30, 2024	USD 59.95	1.70%	United States
33	Solventum Corporation 33 SOLV	2.53	Sept. 30, 2024	USD 74.06	-1.65%	United States
34	Bioventus Inc. 34 BVS	2.47	Sept. 28, 2024	USD 10.50	-1.69%	United States
35	Blueprint Medicines Corporation 35 BPMC	2.40	Sept. 30, 2024	USD 111.50	-0.92%	United States
36	Pilulka Lékárny a.s. 36 PINK.PR	2.34	Dec. 31, 2023	USD 5.24	-1.07%	United States
37	BrightSpring Health Services, Inc. Common Stock 37 BTSG	2.32	Sept. 30, 2024	USD 23.60	-2.64%	United States
38	The Pennant Group, Inc. 38 PNTG	2.29	Sept. 30, 2024	USD 26.62	0.57%	United States
39	Eli Lilly and Company 39 LLY	2.17	Sept. 30, 2024	USD 810.43	-0.08%	United States
40	Apyx Medical Corporation 40 APYX	2.13	Sept. 30, 2024	USD 1.42	-1.39%	United States
41	IQVIA Holdings Inc. 41 IQV	2.11	Sept. 30, 2024	USD 199.11	-1.12%	United States
42	Zynex, Inc. 42 ZYXI	2.04	Sept. 30, 2024	USD 7.73	-1.40%	United States
43	RadNet, Inc. 43 RDNT	1.97	Sept. 30, 2024	USD 66.60	1.73%	United States
44	Puma Biotechnology, Inc. 44 PBYI	1.82	Sept. 30, 2024	USD 2.79	-3.46%	United States
45	Tandem Diabetes Care, Inc. 45 TNDM	1.80	Sept. 30, 2024	USD 36.40	-1.78%	United States
46	The Kroger Co. 46 KR	1.77	Nov. 9, 2024	USD 63.33	2.74%	United States
47	Baxter International Inc. 47 BAX	1.72	Sept. 30, 2024	USD 31.64	-2.83%	United States
48	Surgery Partners, Inc. 48 SGRY	1.69	Sept. 30, 2024	USD 25.30	-0.74%	United States
49	Avid Bioservices, Inc. 49 CDMO	1.67	July 31, 2024	USD 12.48	NA	United States
50	DLH Holdings Corp. 50 DLHC	1.65	Sept. 30, 2024	USD 7.39	-1.47%	United States

1 2 3 4 … 9

Frequently Asked Questions

Which Healthcare company in United States has the highest Debt to Equity Ratio ?

The Healthcare company in United States with the highest Debt to Equity Ratio is Organon & Co. (NYSE: OGN) at 56.71.
Which Healthcare company in United States has the lowest Debt to Equity Ratio ?

The Healthcare company in United States with the lowest Debt to Equity Ratio is Armata Pharmaceuticals, Inc. (NYSE American: ARMP) at -118.03.

What are the top 10 Healthcare companies in United States by Debt to Equity Ratio ?

The top 10 Healthcare companies in United States by Debt to Equity Ratio are Organon & Co., Guardant Health, Inc., Sonida Senior Living, Inc., ModivCare Inc., DaVita Inc., Brookdale Senior Living Inc., Amgen Inc., AbbVie Inc., Travere Therapeutics, Inc. and Halozyme Therapeutics, Inc..
What are the bottom 10 Healthcare companies in United States by Debt to Equity Ratio ?

The bottom 10 Healthcare companies in United States by Debt to Equity Ratio are Armata Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc., HCA Healthcare, Inc., Alnylam Pharmaceuticals, Inc., Insmed Incorporated, Xeris Biopharma Holdings, Inc., LifeMD, Inc., UroGen Pharma Ltd., Champions Oncology, Inc. and Fennec Pharmaceuticals Inc..

Frequently Asked Questions

Don’t Miss A Beat